Fatty Liver, MASH and Medical Weight Loss
Metabolic dysfunction-associated steatotic liver disease (MASLD) ranges from excess liver fat to inflammatory MASH and fibrosis. Normal liver enzymes do not reliably exclude significant disease.
What changes the treatment plan?
Assess fibrosis risk
History, laboratory scores, imaging and specialist testing help identify who needs hepatology evaluation.
Target sustainable reduction
Clinically meaningful weight loss can reduce liver fat and inflammation; larger sustained losses may improve fibrosis in some patients.
Match medication to the patient
Diabetes, cardiovascular disease, kidney health and current product indications influence whether GLP-1/GIP or other therapies are appropriate.
Important precautions
- Using “detox” products as liver treatment
- Assuming ultrasound alone stages fibrosis
- Drinking heavily while ignoring metabolic liver risk
- Rapid unsupervised starvation diets that can create nutritional or gallstone problems
Bring an accurate medication and supplement list. Urgent or unstable symptoms should be evaluated before beginning or intensifying weight-loss treatment.
How W8MD can help
W8MD physicians review the condition, weight trajectory, previous attempts, vital signs, medications, sleep, nutrition, laboratory needs, pregnancy plans, insurance, cost and goals. Treatment may include an FDA-approved obesity medicine, a selected traditional prescription, structured nutrition, sleep care or a medication-free approach.
Medical weight loss · Medication guide · How W8MD chooses treatment · Medication and medical history · Insurance guide · W8MD.com
Frequently asked questions
Can fatty liver be reversed?
Liver fat and inflammation can improve, but established fibrosis needs ongoing assessment.
Does W8MD diagnose cirrhosis?
W8MD can screen metabolic risk and coordinate imaging or specialist referral; advanced disease requires appropriate liver care.
Are weight-loss medicines liver medicines?
Only product-specific labeled indications should be claimed; metabolic benefits do not make every drug an approved MASH treatment.
Evidence-based resources
ADA Standards of Care 2026 · FDA Wegovy information · FDA Zepbound information · WikiMD background article
Request an appointment
For faster assistance call Brooklyn at 718-946-5500 or Philadelphia at 215-676-2334. Do not send personal medical details or urgent concerns through this form.
Medical disclaimer: Educational information only; not medical advice or a guarantee of treatment, coverage, availability or results. Medical evaluation is required. Call 911 for an emergency.
You must be logged in to post a comment.